239 related articles for article (PubMed ID: 34329194)
1. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer.
Kao TJ; Wu CC; Phan NN; Liu YH; Ta HDK; Anuraga G; Wu YF; Lee KH; Chuang JY; Wang CY
Aging (Albany NY); 2021 Jul; 13(14):17970. PubMed ID: 34329194
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients.
Xuan DTM; Wu CC; Kao TJ; Ta HDK; Anuraga G; Andriani V; Athoillah M; Chiao CC; Wu YF; Lee KH; Wang CY; Chuang JY
Aging (Albany NY); 2021 Nov; 13(22):24882-24913. PubMed ID: 34839279
[TBL] [Abstract][Full Text] [Related]
3. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
Feng L; Zhang N; Luo L; Liu J; Yao Y; Gao MS; Pan J; He C
Cancer Manag Res; 2024; 16():95-111. PubMed ID: 38370535
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer.
Chiao CC; Liu YH; Phan NN; An Ton NT; Ta HDK; Anuraga G; Minh Xuan DT; Fitriani F; Putri Hermanto EM; Athoillah M; Andriani V; Ajiningrum PS; Wu YF; Lee KH; Chuang JY; Wang CY; Kao TJ
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943457
[TBL] [Abstract][Full Text] [Related]
6. The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.
Li Y; Huang J; Sun J; Xiang S; Yang D; Ying X; Lu M; Li H; Ren G
Oncotarget; 2017 Jan; 8(3):4501-4519. PubMed ID: 27966459
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma.
Xuan DTM; Yeh IJ; Su CY; Liu HL; Ta HDK; Anuraga G; Chiao CC; Wang CY; Yen MC
Int J Med Sci; 2023; 20(1):87-101. PubMed ID: 36619227
[TBL] [Abstract][Full Text] [Related]
9. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer.
Zhang Y; Yu C
BMC Cancer; 2020 Jun; 20(1):575. PubMed ID: 32560641
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Prognostic and Therapeutic Potentials of the Proteasome 26S Subunit, ATPase (
Ullah MA; Islam NN; Moin AT; Park SH; Kim B
Front Genet; 2022; 13():935286. PubMed ID: 35938038
[TBL] [Abstract][Full Text] [Related]
11. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
[TBL] [Abstract][Full Text] [Related]
12. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
[TBL] [Abstract][Full Text] [Related]
14. Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach.
Choy TK; Wang CY; Phan NN; Khoa Ta HD; Anuraga G; Liu YH; Wu YF; Lee KH; Chuang JY; Kao TJ
Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359286
[TBL] [Abstract][Full Text] [Related]
15. The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma.
Zhang JY; Shi KZ; Liao XY; Li SJ; Bao D; Qian Y; Li DJ
Biomed Res Int; 2021; 2021():9922185. PubMed ID: 34239933
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans.
Liu Y; Yu W; Ren P; Zhang T
Mol Med Rep; 2020 Nov; 22(5):3922-3934. PubMed ID: 33000180
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
Wu M; Li Q; Wang H
Technol Cancer Res Treat; 2021; 20():1533033821992081. PubMed ID: 33550915
[TBL] [Abstract][Full Text] [Related]
19. RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.
Sun CC; Li SJ; Hu W; Zhang J; Zhou Q; Liu C; Li LL; Songyang YY; Zhang F; Chen ZL; Li G; Bi ZY; Bi YY; Gong FY; Bo T; Yuan ZP; Hu WD; Zhan BT; Zhang Q; He QQ; Li DJ
Mol Ther; 2019 Jun; 27(6):1153-1165. PubMed ID: 31010740
[No Abstract] [Full Text] [Related]
20. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
